Literature DB >> 7174402

Control of human airway smooth muscle: in vitro studies.

C Davis, M S Kannan, T R Jones, E E Daniel.   

Abstract

An in vitro study of neural and myogenic control of human tracheal smooth muscle was undertaken. Over 80% of these had active tension and 13% had phasic contractile activity. Tonic and phasic activities were not reversed by indomethacin, 5,8,11,14-eicosatetraynoic acid, methysergide, mepyramine, atropine, or tetrodotoxin (TTX) but were blocked by the calcium antagonist verapamil. In some quiescent strips, tonic and/or phasic activity was induced by exposure to potassium-conductance blockers such as 4-aminopyridine (4-AP) and tetraethylammonium chloride (TEA). Electrical (field) stimulation resulted in frequency-dependent biphasic responses: an initial atropine-sensitive cholinergic contraction followed by a nonadrenergic relaxation. This biphasic response to low stimulus parameters (less than 0.5 ms, less than 15 Hz) was blocked by TTX and scorpion venom and enhanced by 4-AP and TEA, consistent with a neural mechanism. Relaxation responses to longer pulse durations (0.5-1 ms) were not blocked by TTX despite abolition of contraction nor were they enhanced by 4-AP and TEA, suggesting a nonneural mechanism. ATP, adenosine, arachidonate metabolites, histamine, 5-hydroxytryptamine, neurotensin, or vasoactive intestinal polypeptide were ruled out as possible nonadrenergic mediators. The nature and physiological significance of the nonneural inhibitory response remains unknown.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7174402     DOI: 10.1152/jappl.1982.53.5.1080

Source DB:  PubMed          Journal:  J Appl Physiol Respir Environ Exerc Physiol        ISSN: 0161-7567


  15 in total

1.  Non-adrenergic, non-cholinergic neural activation stabilizes smooth-muscle tone independently of eicosanoid factors in guinea-pig isolated airways.

Authors:  A Lindén; A Ullman; C G Löfdahl; B E Skoogh
Journal:  Br J Pharmacol       Date:  1991-10       Impact factor: 8.739

Review 2.  Potassium channels and airway function: new therapeutic prospects.

Authors:  J L Black; P J Barnes
Journal:  Thorax       Date:  1990-03       Impact factor: 9.139

3.  Effect of peptide histidine valine on cardiovascular and respiratory function in normal subjects.

Authors:  E R Chilvers; C M Dixon; Y Yiangou; S R Bloom; P W Ind
Journal:  Thorax       Date:  1988-10       Impact factor: 9.139

4.  Relaxation of cat tracheobronchial and pulmonary arterial smooth muscle by vasoactive intestinal peptide: lack of influence by peptidase inhibitors.

Authors:  R J Altiere; L Diamond
Journal:  Br J Pharmacol       Date:  1984-06       Impact factor: 8.739

5.  Partial inhibition by epithelium of tracheal smooth muscle relaxation induced by the potassium channel activator, BRL 38227.

Authors:  D Pavlovic; E Brione; D De Vernejoul; M Aubier
Journal:  Br J Pharmacol       Date:  1993-09       Impact factor: 8.739

6.  Effect of infused vasoactive intestinal peptide on airway function in normal subjects.

Authors:  J B Palmer; F M Cuss; J B Warren; M Blank; S R Bloom; P J Barnes
Journal:  Thorax       Date:  1986-09       Impact factor: 9.139

7.  VIP antagonists enhance excitatory cholinergic neurotransmission in the human airway.

Authors:  H Aizawa; H Inoue; M Shigyo; S Takata; H Koto; K Matsumoto; N Hara
Journal:  Lung       Date:  1994       Impact factor: 2.584

8.  Cooperation between mast cells and neurons is essential for antigen-mediated bronchoconstriction.

Authors:  Jaime M Cyphert; Martina Kovarova; Irving C Allen; John M Hartney; Dennis L Murphy; Jürgen Wess; Beverly H Koller
Journal:  J Immunol       Date:  2009-06-15       Impact factor: 5.422

9.  The effect of vasoactive intestinal peptide on smooth muscle tone and mucus secretion from the ferret trachea.

Authors:  S E Webber; J G Widdicombe
Journal:  Br J Pharmacol       Date:  1987-05       Impact factor: 8.739

10.  Role of K+ channels in the modulation of cholinergic neural responses in guinea-pig and human airways.

Authors:  M Miura; M G Belvisi; C D Stretton; M H Yacoub; P J Barnes
Journal:  J Physiol       Date:  1992-09       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.